Cargando...
Modulating Th2 Cell Immunity for the Treatment of Asthma
It is estimated that more than 339 million people worldwide suffer from asthma. The leading cause of asthma development is the breakdown of immune tolerance to inhaled allergens, prompting the immune system's aberrant activation. During the early phase, also known as the sensitization phase, al...
Guardado en:
| Publicado en: | Front Immunol |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7902894/ https://ncbi.nlm.nih.gov/pubmed/33643321 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.637948 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|